Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2021
2021 World Conference on Lung Cancer
Presentation Date(s):- September 8 - 14, 2021
- Total Presentations: 1107
-
+
P05 - Early Stage/Localized Disease/Ablative Therapies - SBRT
- Type: Posters
- Track: Early Stage/Localized Disease/Ablative Therapies
- Presentations: 6
- Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
-
+
P05.01 - Personalized Optimization of TCP Using NTCP Based Constraints for Ultracentral Lung Tumors
00:00 - 00:00 | Author(s): Ishita Chen
- Abstract
Loading... -
+
P05.02 - Does Non-Small Cell Lung Cancer Histologic Type Influence Outcomes with Single-Fraction Stereotactic Body Radiotherapy?
00:00 - 00:00 | Presenter: Gregory Videtic
- Abstract
Loading... -
+
P05.03 - Comparison of Stereotactic Body Radiotherapy and Radiofrequency Ablation for Early-Stage NSCLC: A Systemic Review and Pooled Analysis
00:00 - 00:00 | Presenter: Ran Zhang
- Abstract
Loading... -
+
P05.05 - Impact of Lung Stereotactic Body Radiotherapy on Pulmonary Function Test – Experience from Tertiary Cancer Centre in India
00:00 - 00:00 | Presenter: Prachi Vijay Sawant
- Abstract
Loading... -
+
P05.06 - Clinical Application of Anatomical Landmarkers Based 3D Precise Pulmonary Nodule Localization During Thoracoscopic Surgery
00:00 - 00:00 | Author(s): Guangqiang Shao
- Abstract
Loading... -
+
P05.07 - Stereotactic Body Radiotherapy for Early-Stage Non-Small Cell Lung Cancer Without Pretreatment Pathologic Results in a Chinese Population
00:00 - 00:00 | Presenter: Ran Zhang
- Abstract
Loading...
-
+
P06 - Early Stage/Localized Disease/Ablative Therapies - Surgery
- Type: Posters
- Track: Early Stage/Localized Disease/Ablative Therapies
- Presentations: 10
- Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
-
+
P06.01 - Propensity-Matched Analysis Comparing Survival after Thoracoscopic Wedge Resection versus Segmentectomy for cT1N0 Lung Adenocarcinoma
00:00 - 00:00 | Presenter: Mong-Wei Lin
- Abstract
Loading... -
+
P06.02 - Incorporating Surgical Collapse in the Pathological Assessment of Resected Adenocarcinoma in situ of the Lung. A Proof of Principle Study.
00:00 - 00:00 | Presenter: Hans Blaauwgeers
- Abstract
Loading... -
+
P06.03 - The Role of Surgery for Stage 0 Adenocarcinoma in Situ of the Lung: A U.S. National Analysis
00:00 - 00:00 | Presenter: Jessica M. Copeland
- Abstract
Loading... -
+
P06.04 - Clinical Outcomes and Pathological Characteristics of Resected ALK+ Lung Adenocarcinoma: A Single Center Retrospective Analysis
00:00 - 00:00 | Presenter: Zihua Zou
- Abstract
Loading... -
+
P06.05 - Risk Factors for Recurrence According to Site in Resected Stage I Non-Small Cell Lung Cancer
00:00 - 00:00 | Presenter: Satoshi Shiono
- Abstract
Loading... -
+
P06.06 - Clinical Implications of Tumour Spread Through Air Spaces (STAS) In Lung Adenocarcinoma Patients Treated With Surgery
00:00 - 00:00 | Presenter: Laura Gutierrez Sainz
- Abstract
Loading... -
+
P06.07 - Learning Curve in Robotic-Assisted Thoracoscopic Pulmonary Resection: Experience of a Brazilian Surgeon
00:00 - 00:00 | Author(s): Ricardo Mingarini Terra
- Abstract
Loading... -
+
P06.08 - Treatment Outcome of Second Primary Lung Cancer
00:00 - 00:00 | Presenter: Fumihiko Hoshi
- Abstract
Loading... -
+
P06.09 - Lobectomy for Lung Cancer, What Is the Brazilian reality? Brazilian Society of Thoracic Surgeons Analysis
00:00 - 00:00 | Presenter: Maria Teresa Ruiz Tsukazan
- Abstract
Loading... -
+
P06.10 - Low-Cost Video-Assisted Thoracic Surgery (VATS) Lobectomy Versus Regular VATS Lobectomy: A Propensity-Matched Study
00:00 - 00:00 | Presenter: Taiyang Liuru
- Abstract
Loading...
-
+
P07 - Global Health
- Type: Posters
- Track: Global Health
- Presentations: 4
- Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
-
+
P07.01 - Usage Patterns of TKIs in EGFR Mutant NSCLC: Let's Get REAL
00:00 - 00:00 | Presenter: Ullas Batra
- Abstract
Loading... -
+
P07.02 - Real World data of Advanced Non-Small Cell Lung Cancer Patients EGFR Mutated from a Peruvian Cohort
00:00 - 00:00 | Presenter: Marco Antonio Galvez-Nino
- Abstract
Loading... -
+
P07.03 - Lung Cancer Under 50 Years Old – What Reality Taught Us
00:00 - 00:00 | Presenter: Francisco Neri
- Abstract
Loading... -
+
P07.04 - Primary Lung Cancers in Patients With Head and Neck Cancer: Experience of a French Institution
00:00 - 00:00 | Presenter: Christelle Clément-Duchêne
- Abstract
Loading...
-
+
P08 - Health Services Research/Health Economics - Factors Affecting Clinical Outcomes
- Type: Posters
- Track: Health Services Research/Health Economics
- Presentations: 5
- Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
-
+
P08.01 - Building Personalized Follow-Up Care Through AI by Bringing the Lung Cancer Patient, Data Scientist and Oncologist Together
00:00 - 00:00 | Presenter: Maria Torrente
- Abstract
Loading... -
+
P08.02 - Lorlatinib in First Line Treatment of Patients With ALK-Positive NSCLC: A Network Meta-Analysis
00:00 - 00:00 | Author(s): Joanne Gregory
- Abstract
Loading... -
+
P08.03 - Cost‑Effectiveness of Pembrolizumab With or Without Chemotherapy for Stage IV Non‑Squamous NSCLC with High PD‑L1 in Switzerland
00:00 - 00:00 | Presenter: Esther Pardo
- Abstract
Loading... -
+
P08.04 - Comparative Clinical Outcomes Between EGFR Exon20ins and Wildtype NSCLC Treated with Immune Checkpoint Inhibitors
00:00 - 00:00 | Presenter: Lyudmila Bazhenova
- Abstract
Loading... -
+
P08.05 - Impact of Personal Characteristics on the Effectiveness of Immunotherapy Treatment in Late-Stage NSCLC: A Systematic Review
00:00 - 00:00 | Presenter: Krishna Patel
- Abstract
Loading...
-
+
P09 - Health Services Research/Health Economics - Lung Cancer Policy
- Type: Posters
- Track: Health Services Research/Health Economics
- Presentations: 7
- Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
-
+
P09.01 - Waiting Time and Lung Cancer Outcomes: Association and Methodological Results From a Systematic Review of Systematic and Scoping Reviews
00:00 - 00:00 | Presenter: Jianrong Zhang
- Abstract
Loading... -
+
P09.02 - A Clinical Evaluation Algorithm to Define Clinical Utility of Lung Nodule Diagnosis in a Multi-Collaborator Setting Using Real World Data
00:00 - 00:00 | Presenter: Stephen Deppen
- Abstract
Loading... -
+
P09.03 - Validation of a Real-World Mortality Endpoint for Advanced Non-Small Cell Lung Cancer Patients in China
00:00 - 00:00 | Presenter: Xian-ce Tang
- Abstract
Loading... -
+
P09.04 - Evaluating Mutational Differences Between Hispanics and Asians in NSCLC
00:00 - 00:00 | Presenter: Robert Chun-Hao Hsu
- Abstract
Loading... -
+
P09.05 - Variation of Treatment Recommendations for Stage III Non-Small-Cell Lung Cancer by Stage and Actionable Mutations
00:00 - 00:00 | Presenter: Dylann K Fujimoto
- Abstract
Loading... -
+
P09.06 - Patient Behaviors and Attitudes Towards Lung Cancer Medication Adherence
00:00 - 00:00 | Author(s): Paris Kosmidis
- Abstract
Loading... -
+
P09.07 - Integration of Smoking Cessation Services in Mobile Mammography and Mobile COVID Screening to Reach Rural Populations
00:00 - 00:00 | Presenter: Haylie Reed
- Abstract
Loading...
-
+
P10 - Health Services Research/Health Economics - What Happens In The Real-World?
- Type: Posters
- Track: Health Services Research/Health Economics
- Presentations: 14
- Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
-
+
P10.01 - Real World Data of Clinical Trial Eligibility and Outcome Analysis in Patients With Metastatic NSCLC
00:00 - 00:00 | Presenter: AMULYA YELLALA
- Abstract
Loading... -
+
P10.02 - Improved Survival of Elderly Patients with NSCLC Treated in the Immunotherapy Era: A Historical Cohort Study
00:00 - 00:00 | Presenter: Giacomo Pelizzari
- Abstract
Loading... -
+
P10.03 - Pembrolizumab With or Without Chemotherapy for Advanced Lung Cancer: A Real-World Analysis of Key Prognostic Factors
00:00 - 00:00 | Presenter: Shirish M. Gadgeel
- Abstract
Loading... -
+
P10.04 - Immunotherapy-Treated Non-Small Cell Lung Cancer Patients With Sensitizing Gene Alterations: A Real World Survival Analysis
00:00 - 00:00 | Presenter: Leia Khaddour
- Abstract
Loading... -
+
P10.05 - Adherence to Treatment Recommendations From Multidisciplinary Tumor Boards
00:00 - 00:00 | Presenter: Julia Roeper
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
P10.06 - Affiliation to the Labour Market in Denmark for Patients Under 60 Years of Age After Diagnosis and Treatment for ALK-Positive NSCLC
00:00 - 00:00 | Presenter: Jon Lykkegaard Andersen
- Abstract
Loading... -
+
P10.07 - Real-World US Treatment Patterns and Clinical Outcomes in Advanced NSCLC After Prior Platinum Chemotherapy and Immunotherapy
00:00 - 00:00 | Presenter: Timothy W. Smith
- Abstract
Loading... -
+
P10.08 - Comparing Lung Cancer in Never Smokers and Ever Smokers in Asian or Asian American Patients Treated at a Tertiary Urban Public Hospital in New York
00:00 - 00:00 | Presenter: Gianna Kroening
- Abstract
Loading... -
+
P10.09 - Efficacy and Toxicity of EGFR-TKI in Frail NSCLC with EGFR Mutation: A Retrospective Analysis in a Single Institution
00:00 - 00:00 | Presenter: yuki akazawa
- Abstract
Loading... -
+
P10.10 - Trends in Treatment Patterns and Survival in Advanced NSCLC Patients Treated at Frankfurt University Hospital in 2012–2018
00:00 - 00:00 | Presenter: Andrea Wolf
- Abstract
Loading... -
+
P10.11 - Real-World Experience With Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer at Frankfurt University Hospital
00:00 - 00:00 | Author(s): Shabnam Shaid
- Abstract
Loading... -
+
P10.12 - A Thorough Look at the Clinical Characteristics and Disease Burden of Lung Cancer Patients in Chinese County Area
00:00 - 00:00 | Presenter: Jun Wan
- Abstract
Loading... -
+
P10.13 - Real World Outcomes for Non Small Cell Lung Cancer Treated With Checkpoint Inhibitors in Lebanon, A Multicenter Observational Study
00:00 - 00:00 | Presenter: Fadi Louis Nasr
- Abstract
Loading... -
+
P10.14 - ctDNA and Real-World Response (rwR) in Patients With Lung Cancer From A Prospective Real-World Clinico-Genomic (PCG) Study
00:00 - 00:00 | Presenter: Ari VanderWalde
- Abstract
Loading...
-
+
P11 - Immuno-biology and Novel Immunotherapeutics (Phase I and Translational) - Clinical Trials in Progress
- Type: Posters
- Track: Immuno-biology and Novel Immunotherapeutics (Phase I and Translational)
- Presentations: 3
- Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
-
+
P11.01 - Phase I Trial of in Situ Vaccination With Autologous CCL21-Modified Dendritic Cells (CCL21-DC) Combined With Pembrolizumab for Advanced NSCLC
00:00 - 00:00 | Author(s): Aaron E Lisberg
- Abstract
Loading... -
+
P11.02 - Targeting the Tumor Neovasculature in Lung Cancer: A Phase I Study of AMG 160 in Subjects With Non-Small Cell Lung Cancer
00:00 - 00:00 | Presenter: George Blumenschein, Jr
- Abstract
Loading... -
+
P11.03 - SHR-1316 in Combination With Fluzoparib in Relapsed Small-Cell Lung Cancer: An Open-Label, Multicenter, Two-Stage, Phase Ⅰb Trial
00:00 - 00:00 | Presenter: Yun Fan
- Abstract
Loading...
-
+
P12 - Immuno-biology and Novel Immunotherapeutics (Phase I and Translational) - Clinical Efficacy of ICI, Predicitve Biomarkers and RT Plus ICI
- Type: Posters
- Track: Immuno-biology and Novel Immunotherapeutics (Phase I and Translational)
- Presentations: 7
- Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
-
+
P12.01 - A Novel 89Zr-α-PD-1 Immuno-PET-CT May Improve Pseudoprogression Detection in a Lung Cancer Murine Model Receiving Immunotherapy
00:00 - 00:00 | Author(s): Ander Puyalto
- Abstract
Loading... -
+
P12.02 - Systemic Anticancer Therapy Upregulate Plasma Levels of Damage-Associated Molecular Patterns in Patients With Advanced Lung Cancer
00:00 - 00:00 | Presenter: Hiroyuki Inoue
- Abstract
Loading... -
+
P12.03 - The Time of Anti-PD-1 Infusion Improves Survival Outcomes by Fasting Conditions Simulation in Non-Small Cell Lung Cancer
00:00 - 00:00 | Presenter: Anna Vilalta-Lacarra
- Abstract
Loading... -
+
P12.04 - Radiation Mediates IDO1 Dynamic Changes in KRAS Mutation Lung Cancer Cell Lines
00:00 - 00:00 | Presenter: Yanli Lan
- Abstract
Loading... -
+
P12.05 - Neutrophil Elastase as Combined Immunotherapy Target for Treating NSCLC
00:00 - 00:00 | Presenter: Hong Cheng
- Abstract
Loading... -
+
P12.06 - Computational Omics Biology Model (CBM) Identifies PD-L1 Immunotherapy Response Criteria Based on Genomic Signature of NSCLC
00:00 - 00:00 | Presenter: Michael Castro
- Abstract
Loading... -
+
P12.07 - Radiation Mediated Down-Regulation of Indoleamine 2,3-dioxygenase 1 (IDO1) Expression in Lung Cancer Cells is Associated with iNOS-NO Pathway
00:00 - 00:00 | Presenter: Wenhu Pi
- Abstract
Loading...
-
+
P13 - Immunotherapy (Phase II/III Trials) - Clinical Efficacy of ICI, Predictive Biomarkers and RT Plus ICI
- Type: Posters
- Track: Immunotherapy (Phase II/III Trials)
- Presentations: 1
- Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
-
+
P13.01 - Use of Antibiotics Is Associated With an Increase in Immunotherapy Related Adverse Effects in Patients With Non-Small Cell Lung Cancer
00:00 - 00:00 | Presenter: umair majeed
- Abstract
Loading...
-
+
P14 - Immunotherapy (Phase II/III Trials) - Clinical Trial in Progress
- Type: Posters
- Track: Immunotherapy (Phase II/III Trials)
- Presentations: 7
- Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
-
+
P14.01 - Phase 3 Study of First-Line Pembrolizumab ± Vibostolimab (anti-TIGIT) in Patients With PD-L1‒Positive Metastatic NSCLC
00:00 - 00:00 | Presenter: Matthew D. Hellmann
- Abstract
Loading... -
+
P14.02 - Phase III Trial of Pembrolizumab‑Chemotherapy Versus Pembrolizumab in First‑Line of Advanced NSCLC with PD‑L1 ≥50%: PERSEE
00:00 - 00:00 | Presenter: Renaud Descourt
- Abstract
Loading... -
+
P14.03 - Vibostolimab Plus Pembrolizumab With/Without Docetaxel vs Docetaxel in NSCLC After Platinum Chemotherapy and Immunotherapy
00:00 - 00:00 | Presenter: Solange Peters
- Abstract
Loading... -
+
P14.04 - A Phase 2 Multicenter Study of Iovance Autologous Tumor Infiltrating Lymphocytes (TIL, LN-145) Cell Therapy in Patients With Metastatic NSCLC
00:00 - 00:00 | Presenter: Erminia Massarelli
- Abstract
Loading... -
+
P14.05 - Phase 2, Study of Iovance Autologous Tumor Infiltrating Lymphocytes (Lifileucel, LN-144, LN-145, LN-145-S1) In Patients With Solid Tumors
00:00 - 00:00 | Presenter: Scott Gettinger
- Abstract
Loading... -
+
P14.06 - Toripalimab in Combination With Bevacizumab and Platinum-Based Chemotherapy in Patients with Untreated Advanced PSC: A Phase II Study
00:00 - 00:00 | Presenter: Juan Li
- Abstract
Loading... -
+
P14.07 - PERLA: Randomized Phase II Trial of Dostarlimab + Chemotherapy (CT) vs Pembrolizumab + CT in Metastatic Non-Squamous NSCLC
00:00 - 00:00 | Presenter: Alexander Spira
- Abstract
Loading...
first
prev
